SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-20-013394
Filing Date
2020-06-18
Accepted
2020-06-18 13:26:42
Documents
17
Period of Report
2020-06-18
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K vxrt20200618_8k.htm 8-K 31120
2 EXHIBIT 99.1 ex_190853.htm EX-99.1 9313
3 a01.jpg GRAPHIC 35612
4 a02.jpg GRAPHIC 189841
5 a03.jpg GRAPHIC 85881
6 a04.jpg GRAPHIC 115334
7 a05.jpg GRAPHIC 100717
8 a06.jpg GRAPHIC 91813
9 a07.jpg GRAPHIC 66816
10 a08.jpg GRAPHIC 73650
11 a09.jpg GRAPHIC 87210
12 a10.jpg GRAPHIC 49170
13 a11.jpg GRAPHIC 78195
14 a12.jpg GRAPHIC 61303
15 a13.jpg GRAPHIC 103697
16 a14.jpg GRAPHIC 84524
17 a15.jpg GRAPHIC 35612
  Complete submission text file 0001437749-20-013394.txt   1777559
Mailing Address 385 OYSTER POINT BOULEVARD, SUITE 9A SOUTH SAN FRANCISCO CA 94080
Business Address 385 OYSTER POINT BOULEVARD, SUITE 9A SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 20971937
SIC: 2836 Biological Products, (No Diagnostic Substances)